4//SEC Filing
DeLong Mark Jeffrey 4
Accession 0001127602-25-001831
CIK 0001492422other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 3:23 PM ET
Size
4.5 KB
Accession
0001127602-25-001831
Insider Transaction Report
Form 4
DeLong Mark Jeffrey
Chief Business & Strat Officer
Transactions
- Sale
Common Stock
2025-01-22$30.43/sh−1,396$42,474→ 84,673 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 21, 2025.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001856078
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 3:23 PM ET
- Size
- 4.5 KB